BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
878850	O[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1	InChI=1S/C29H30ClFN4O3/c30-21-9-11-22(12-10-21)33-29(38)35-17-23(36)15-26(35)28(37)34-25-14-20(8-13-24(25)31)27(32-16-18-6-7-18)19-4-2-1-3-5-19/h1-5,8-14,18,23,26-27,32,36H,6-7,15-17H2,(H,33,38)(H,34,37)/t23-,26-,27?/m1/s1	HBBZGIHYHHTCAB-UTZIHYNGSA-N	433366	US10562850, Compound 1p::US10562850, Compound 3a::US11066360, Compound 3a	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433366	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433366&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281863	438642299							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878851	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C32H33ClFN5O3/c1-42-26-17-29(39(19-26)31(41)37-25-10-8-24(33)9-11-25)30(40)38-28-16-23(7-12-27(28)34)32(36,14-13-20-5-6-20)22-4-2-3-21(15-22)18-35/h2-4,7-12,15-16,20,26,29H,5-6,13-14,17,19,36H2,1H3,(H,37,41)(H,38,40)/t26-,29-,32?/m1/s1	YTGQPSYAWGTQEE-IYGDAUFUSA-N	433367	US10562850, Compound 17b::US11066360, Compound 17b	Plasma kallikrein	Human	 75.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433367	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433367&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359623	438642300							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878852	CC(C)(C)[S@](=O)NC(CCC1CC1)(c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1)c1ccccn1	InChI=1S/C33H39ClFN5O4S/c1-32(2,3)45(44)39-33(16-15-21-7-8-21,29-6-4-5-17-36-29)22-9-14-26(35)27(18-22)38-30(42)28-19-25(41)20-40(28)31(43)37-24-12-10-23(34)11-13-24/h4-6,9-14,17-18,21,25,28,39,41H,7-8,15-16,19-20H2,1-3H3,(H,37,43)(H,38,42)/t25-,28-,33?,45+/m1/s1	JEVCIJSWWNTRIA-SMAHILNNSA-N	433368	US10562850, Compound 61b::US11066360, Compound 61b	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433368	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433368&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750145	438642301							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878853	O[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1ccccc1F	InChI=1S/C18H17ClFN3O3/c19-11-5-7-12(8-6-11)21-18(26)23-10-13(24)9-16(23)17(25)22-15-4-2-1-3-14(15)20/h1-8,13,16,24H,9-10H2,(H,21,26)(H,22,25)/t13-,16-/m1/s1	YIUKCJACECLDEF-CZUORRHYSA-N	433369	US10562850, Compound 2a::US11066360, Compound 2a	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433369	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433369&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359279	438642302							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878854	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C31H32ClFN6O3/c1-42-24-15-27(39(18-24)30(41)38-28-10-8-23(32)17-36-28)29(40)37-26-14-22(7-9-25(26)33)31(35,12-11-19-5-6-19)21-4-2-3-20(13-21)16-34/h2-4,7-10,13-14,17,19,24,27H,5-6,11-12,15,18,35H2,1H3,(H,37,40)(H,36,38,41)/t24-,27-,31?/m1/s1	XHEUJDABOZVRIR-QPLSPKJVSA-N	433370	US10562850, Compound 18b::US11066360, Compound 18b	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433370	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433370&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359297	438642303							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878855	O[C@@]1(C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(NC(=O)Nc1ccc(Cl)cc1)c1cccc(c1)C#N)c1ccccc1	InChI=1S/C44H39Cl2FN6O4/c45-33-12-16-35(17-13-33)49-41(55)52-44(22-21-28-9-10-28,31-8-4-5-29(23-31)26-48)32-11-20-37(47)38(24-32)51-40(54)39-25-43(57,30-6-2-1-3-7-30)27-53(39)42(56)50-36-18-14-34(46)15-19-36/h1-8,11-20,23-24,28,39,57H,9-10,21-22,25,27H2,(H,50,56)(H,51,54)(H2,49,52,55)/t39-,43-,44?/m1/s1	UCADJOBQLTWIBK-TVHZFVKUSA-N	433371	US10562850, Compound 30b::US11066360, Compound 30b	Plasma kallikrein	Human	 75.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433371	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433371&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359527	438642304							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878856	O[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1ccccc1	InChI=1S/C29H30ClFN4O3/c30-21-9-11-22(12-10-21)33-29(38)35-17-23(36)15-26(35)28(37)34-25-14-20(8-13-24(25)31)27(32-16-18-6-7-18)19-4-2-1-3-5-19/h1-5,8-14,18,23,26-27,32,36H,6-7,15-17H2,(H,33,38)(H,34,37)/t23-,26-,27?/m1/s1	HBBZGIHYHHTCAB-UTZIHYNGSA-N	433366	US10562850, Compound 1p::US10562850, Compound 3a::US11066360, Compound 3a	Plasma kallikrein	Human	 75.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433366	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433366&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281863	438642299							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878857	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(N[S@](=O)C(C)(C)C)c1cccc(c1)C#N	InChI=1S/C35H40ClFN6O4S/c1-34(2,3)48(46)42-35(15-14-22-8-9-22,24-7-5-6-23(16-24)19-38)25-10-12-28(37)29(17-25)40-32(44)30-18-27(47-4)21-43(30)33(45)41-31-13-11-26(36)20-39-31/h5-7,10-13,16-17,20,22,27,30,42H,8-9,14-15,18,21H2,1-4H3,(H,40,44)(H,39,41,45)/t27-,30-,35?,48-/m1/s1	VAASFQVGQYBRMC-BEGVHSJBSA-N	433373	US10562850, Compound 18a::US11066360, Compound 18a	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433373	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433373&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750015	438642305							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878858	NC(CCC1CC1)(c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cn2)c1)c1ccccn1	InChI=1S/C28H30ClFN6O3/c29-19-7-9-25(33-15-19)35-27(39)36-16-20(37)14-23(36)26(38)34-22-13-18(6-8-21(22)30)28(31,11-10-17-4-5-17)24-3-1-2-12-32-24/h1-3,6-9,12-13,15,17,20,23,37H,4-5,10-11,14,16,31H2,(H,34,38)(H,33,35,39)/t20-,23-,28?/m1/s1	KXFZKEZPEDQJMM-JLGCCPRNSA-N	433374	US10562850, Compound 62c::US11066360, Compound 62c	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433374	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433374&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359241	438642306							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878859	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C31H31ClFN5O3/c32-23-7-9-24(10-8-23)36-30(41)38-18-25(39)16-28(38)29(40)37-27-15-22(6-11-26(27)33)31(35,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,25,28,39H,4-5,12-13,16,18,35H2,(H,36,41)(H,37,40)/t25-,28-,31?/m1/s1	ZSOTVUHHWYEFAC-JADDJLNISA-N	433375	US10562850, Compound 4g::US11066360, Compound 4g	Plasma kallikrein	Human	 75.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433375	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433375&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359354	438642307							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878860	N[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C31H32ClFN6O2/c32-23-7-9-25(10-8-23)37-30(41)39-18-24(35)16-28(39)29(40)38-27-15-22(6-11-26(27)33)31(36,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,24,28H,4-5,12-13,16,18,35-36H2,(H,37,41)(H,38,40)/t24-,28-,31?/m1/s1	TXDNHUJHLZWLQW-LLAOLMGESA-N	433376	US10562850, Compound 19c::US11066360, Compound 19c	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433376	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433376&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359601	438642308							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878861	NC(CCC1CC1)(c1ccc(cc1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C31H31ClFN5O3/c32-23-8-10-24(11-9-23)36-30(41)38-18-25(39)16-28(38)29(40)37-27-15-22(7-12-26(27)33)31(35,14-13-19-1-2-19)21-5-3-20(17-34)4-6-21/h3-12,15,19,25,28,39H,1-2,13-14,16,18,35H2,(H,36,41)(H,37,40)/t25-,28-,31?/m1/s1	NNIFNVSICNCVCW-JADDJLNISA-N	433377	US10562850, Compound 63g::US11066360, Compound 63g	Plasma kallikrein	Human	 75.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433377	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433377&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359504	438642309							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878862	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C31H31ClFN5O3/c32-23-7-9-24(10-8-23)36-30(41)38-18-25(39)16-28(38)29(40)37-27-15-22(6-11-26(27)33)31(35,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,25,28,39H,4-5,12-13,16,18,35H2,(H,36,41)(H,37,40)/t25-,28+,31?/m1/s1	ZSOTVUHHWYEFAC-LHPFXVGBSA-N	433378	US10562850, Compound 5e::US11066360, Compound 5e	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433378	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433378&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281905	438642310					C04398		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878863	N[C@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C31H32ClFN6O2/c32-23-7-9-25(10-8-23)37-30(41)39-18-24(35)16-28(39)29(40)38-27-15-22(6-11-26(27)33)31(36,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,24,28H,4-5,12-13,16,18,35-36H2,(H,37,41)(H,38,40)/t24-,28+,31?/m0/s1	TXDNHUJHLZWLQW-MPAODNJVSA-N	433379	US10562850, Compound 33d::US11066360, Compound 33d	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433379	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433379&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359561	438642311							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878864	NC(CCC1CC1)(c1cccnc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C29H31ClFN5O3/c30-21-6-8-22(9-7-21)34-28(39)36-17-23(37)15-26(36)27(38)35-25-14-19(5-10-24(25)31)29(32,12-11-18-3-4-18)20-2-1-13-33-16-20/h1-2,5-10,13-14,16,18,23,26,37H,3-4,11-12,15,17,32H2,(H,34,39)(H,35,38)/t23-,26-,29?/m1/s1	GXRAZUOSZNNHEA-XATCSJPRSA-N	433382	US10562850, Compound 64g::US11066360, Compound 64g	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433382	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433382&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359617	438642314							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878865	CO[C@@H]1C[C@H](N(C1)C(=O)N(C)c1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C33H35ClFN5O3/c1-39(26-11-9-25(34)10-12-26)32(42)40-20-27(43-2)18-30(40)31(41)38-29-17-24(8-13-28(29)35)33(37,15-14-21-6-7-21)23-5-3-4-22(16-23)19-36/h3-5,8-13,16-17,21,27,30H,6-7,14-15,18,20,37H2,1-2H3,(H,38,41)/t27-,30+,33?/m1/s1	FPWZXKOIXOEUQB-RDJZJCQLSA-N	433383	US10562850, Compound 6f::US11066360, Compound 6f	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433383	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433383&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359365	438642315							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878866	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2CC(=O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C31H29ClFN5O3/c32-23-7-9-24(10-8-23)36-30(41)38-18-25(39)16-28(38)29(40)37-27-15-22(6-11-26(27)33)31(35,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,28H,4-5,12-13,16,18,35H2,(H,36,41)(H,37,40)/t28-,31?/m1/s1	QMSQFJCSTHFEIQ-ZZTVPSNHSA-N	433384	US10562850, Compound 20b::US11066360, Compound 20b	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433384	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433384&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359348	438642316							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878867	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1	InChI=1S/C30H33ClFN5O3/c1-40-23-17-26(37(18-23)29(39)35-22-10-8-21(31)9-11-22)28(38)36-25-16-20(7-12-24(25)32)30(33,14-13-19-5-6-19)27-4-2-3-15-34-27/h2-4,7-12,15-16,19,23,26H,5-6,13-14,17-18,33H2,1H3,(H,35,39)(H,36,38)/t23-,26-,30?/m1/s1	VXUMWJIENCDFKX-JRSXUWQBSA-N	433385	US10562850, Compound 65b::US11066360, Compound 65b	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433385	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433385&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359647	438642317							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878868	CO[C@@H]1C[C@@H](N(C1)C(=O)N(C)c1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C33H35ClFN5O3/c1-39(26-11-9-25(34)10-12-26)32(42)40-20-27(43-2)18-30(40)31(41)38-29-17-24(8-13-28(29)35)33(37,15-14-21-6-7-21)23-5-3-4-22(16-23)19-36/h3-5,8-13,16-17,21,27,30H,6-7,14-15,18,20,37H2,1-2H3,(H,38,41)/t27-,30-,33?/m1/s1	FPWZXKOIXOEUQB-QDZZTBPHSA-N	433386	US10562850, Compound 6e::US11066360, Compound 6e	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433386	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433386&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359618	438642318							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878869	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccccc2)c1	InChI=1S/C31H32FN5O3/c32-26-12-11-23(31(34,14-13-20-9-10-20)22-6-4-5-21(15-22)18-33)16-27(26)36-29(39)28-17-25(38)19-37(28)30(40)35-24-7-2-1-3-8-24/h1-8,11-12,15-16,20,25,28,38H,9-10,13-14,17,19,34H2,(H,35,40)(H,36,39)/t25-,28-,31?/m1/s1	BHZFWFPHPBCYRY-JADDJLNISA-N	433387	US10562850, Compound 21d::US11066360, Compound 21d	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433387	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433387&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359590	438642319							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878870	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1	InChI=1S/C29H32ClFN6O3/c1-40-21-15-24(37(17-21)28(39)36-26-10-8-20(30)16-34-26)27(38)35-23-14-19(7-9-22(23)31)29(32,12-11-18-5-6-18)25-4-2-3-13-33-25/h2-4,7-10,13-14,16,18,21,24H,5-6,11-12,15,17,32H2,1H3,(H,35,38)(H,34,36,39)/t21-,24-,29?/m1/s1	HMKGSFLIMYOEKX-ZORXERLGSA-N	433388	BDBM433391::US10562850, Compound 36d::US10562850, Compound 37d::US11066360, Compound 37d	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359283	438642320							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878871	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2CCCN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C31H31ClFN5O2/c32-24-9-11-25(12-10-24)36-30(40)38-16-2-5-28(38)29(39)37-27-18-23(8-13-26(27)33)31(35,15-14-20-6-7-20)22-4-1-3-21(17-22)19-34/h1,3-4,8-13,17-18,20,28H,2,5-7,14-16,35H2,(H,36,40)(H,37,39)/t28-,31?/m1/s1	LISQDGOQHUHLHR-ZZTVPSNHSA-N	433389	US10562850, Compound 7c::US11066360, Compound 7c	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433389	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433389&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359645	438642321							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878872	Cc1ccc(NC(=O)N2C[C@H](O)C[C@@H]2C(=O)Nc2cc(ccc2F)C(N)(CCC2CC2)c2cccc(c2)C#N)cc1	InChI=1S/C32H34FN5O3/c1-20-5-10-25(11-6-20)36-31(41)38-19-26(39)17-29(38)30(40)37-28-16-24(9-12-27(28)33)32(35,14-13-21-7-8-21)23-4-2-3-22(15-23)18-34/h2-6,9-12,15-16,21,26,29,39H,7-8,13-14,17,19,35H2,1H3,(H,36,41)(H,37,40)/t26-,29-,32?/m1/s1	IWZUFFQUBYJSIV-IYGDAUFUSA-N	433390	US10562850, Compound 22b::US11066360, Compound 22b	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433390	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433390&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359621	438642322							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878873	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1	InChI=1S/C29H32ClFN6O3/c1-40-21-15-24(37(17-21)28(39)36-26-10-8-20(30)16-34-26)27(38)35-23-14-19(7-9-22(23)31)29(32,12-11-18-5-6-18)25-4-2-3-13-33-25/h2-4,7-10,13-14,16,18,21,24H,5-6,11-12,15,17,32H2,1H3,(H,35,38)(H,34,36,39)/t21-,24-,29?/m1/s1	HMKGSFLIMYOEKX-ZORXERLGSA-N	433388	BDBM433391::US10562850, Compound 36d::US10562850, Compound 37d::US11066360, Compound 37d	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359283	438642320							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878874	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@@H]2CCCN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C31H31ClFN5O2/c32-24-9-11-25(12-10-24)36-30(40)38-16-2-5-28(38)29(39)37-27-18-23(8-13-26(27)33)31(35,15-14-20-6-7-20)22-4-1-3-21(17-22)19-34/h1,3-4,8-13,17-18,20,28H,2,5-7,14-16,35H2,(H,36,40)(H,37,39)/t28-,31?/m0/s1	LISQDGOQHUHLHR-NPHAVVRNSA-N	433392	US10562850, Compound 8c::US11066360, Compound 8c	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433392	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433392&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359611	438642323							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878875	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Br)cc2)c1	InChI=1S/C31H31BrFN5O3/c32-23-7-9-24(10-8-23)36-30(41)38-18-25(39)16-28(38)29(40)37-27-15-22(6-11-26(27)33)31(35,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,25,28,39H,4-5,12-13,16,18,35H2,(H,36,41)(H,37,40)/t25-,28-,31?/m1/s1	LKZRDRGVMHMUQQ-JADDJLNISA-N	433393	US10562850, Compound 23b::US11066360, Compound 23b	Plasma kallikrein	Human	 75.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433393	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433393&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281908	438642324							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878876	NC(CCC1CC1)(c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cc2)c2ccccc2)c1)c1ccccn1	InChI=1S/C35H35ClFN5O3/c36-26-12-14-27(15-13-26)40-33(44)42-22-34(45,24-6-2-1-3-7-24)21-30(42)32(43)41-29-20-25(11-16-28(29)37)35(38,18-17-23-9-10-23)31-8-4-5-19-39-31/h1-8,11-16,19-20,23,30,45H,9-10,17-18,21-22,38H2,(H,40,44)(H,41,43)/t30-,34-,35?/m1/s1	QSEWLZJVGPKOAW-WELJHWQCSA-N	433394	US10562850, Compound 31i::US11066360, Compound 31i	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433394	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433394&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359587	438642325							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878877	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C31H31ClFN5O3/c32-23-7-9-24(10-8-23)36-30(41)38-18-25(39)16-28(38)29(40)37-27-15-22(6-11-26(27)33)31(35,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,25,28,39H,4-5,12-13,16,18,35H2,(H,36,41)(H,37,40)/t25-,28+,31?/m0/s1	ZSOTVUHHWYEFAC-RKPVUUMKSA-N	433395	US10562850, Compound 9c::US11066360, Compound 9c	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433395	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433395&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359482	438642326							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878878	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(F)cc2)c1	InChI=1S/C31H31F2N5O3/c32-23-7-9-24(10-8-23)36-30(41)38-18-25(39)16-28(38)29(40)37-27-15-22(6-11-26(27)33)31(35,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,25,28,39H,4-5,12-13,16,18,35H2,(H,36,41)(H,37,40)/t25-,28-,31?/m1/s1	CEXKWMHOXZZHFS-JADDJLNISA-N	433396	US10562850, Compound 24b::US11066360, Compound 24b	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433396	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433396&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359547	438642327							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878879	NC(CCC1CC1)(c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cn2)c2ccccc2)c1)c1ccccn1	InChI=1S/C34H34ClFN6O3/c35-25-12-14-30(39-20-25)41-32(44)42-21-33(45,23-6-2-1-3-7-23)19-28(42)31(43)40-27-18-24(11-13-26(27)36)34(37,16-15-22-9-10-22)29-8-4-5-17-38-29/h1-8,11-14,17-18,20,22,28,45H,9-10,15-16,19,21,37H2,(H,40,43)(H,39,41,44)/t28-,33-,34?/m1/s1	CSRIYPJRLBVGQK-WHGMDWNTSA-N	433397	US10562850, Compound 32a::US11066360, Compound 32a	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433397	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433397&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359570	438642328							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878880	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@@H]2C[C@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C31H31ClFN5O3/c32-23-7-9-24(10-8-23)36-30(41)38-18-25(39)16-28(38)29(40)37-27-15-22(6-11-26(27)33)31(35,13-12-19-4-5-19)21-3-1-2-20(14-21)17-34/h1-3,6-11,14-15,19,25,28,39H,4-5,12-13,16,18,35H2,(H,36,41)(H,37,40)/t25-,28-,31?/m0/s1	ZSOTVUHHWYEFAC-RXKSKBTASA-N	433398	US10562850, Compound 10c::US11066360, Compound 10c	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433398	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433398&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359568	438642329							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878881	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(cc2)[N+]([O-])=O)c1	InChI=1S/C31H31FN6O5/c32-26-11-6-22(31(34,13-12-19-4-5-19)21-3-1-2-20(14-21)17-33)15-27(26)36-29(40)28-16-25(39)18-37(28)30(41)35-23-7-9-24(10-8-23)38(42)43/h1-3,6-11,14-15,19,25,28,39H,4-5,12-13,16,18,34H2,(H,35,41)(H,36,40)/t25-,28-,31?/m1/s1	GOFUDLSJSSMFGH-JADDJLNISA-N	433399	US10562850, Compound 25b::US11066360, Compound 25b	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433399	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433399&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359649	438642330					C02125		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878882	O[C@@]1(C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(NC(=O)Nc1ccc(Cl)cn1)c1ccccn1)c1ccccc1	InChI=1S/C40H37Cl2FN8O4/c41-28-12-15-34(45-22-28)48-37(53)50-40(18-17-25-9-10-25,33-8-4-5-19-44-33)27-11-14-30(43)31(20-27)47-36(52)32-21-39(55,26-6-2-1-3-7-26)24-51(32)38(54)49-35-16-13-29(42)23-46-35/h1-8,11-16,19-20,22-23,25,32,55H,9-10,17-18,21,24H2,(H,47,52)(H,46,49,54)(H2,45,48,50,53)/t32-,39-,40?/m1/s1	LHPFAIGHMVQELS-HLYQHIASSA-N	433400	US10562850, Compound 32b::US11066360, Compound 32b	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359518	438642331							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878883	CO[C@H]1C[C@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C32H33ClFN5O3/c1-42-26-17-29(39(19-26)31(41)37-25-10-8-24(33)9-11-25)30(40)38-28-16-23(7-12-27(28)34)32(36,14-13-20-5-6-20)22-4-2-3-21(15-22)18-35/h2-4,7-12,15-16,20,26,29H,5-6,13-14,17,19,36H2,1H3,(H,37,41)(H,38,40)/t26-,29-,32?/m0/s1	YTGQPSYAWGTQEE-RCESYNESSA-N	433401	US10562850, Compound 11e::US11066360, Compound 11e	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433401	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433401&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281907	438642332							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878884	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2cccc3ccccc23)c1	InChI=1S/C35H34FN5O3/c36-29-14-13-26(35(38,16-15-22-11-12-22)25-8-3-5-23(17-25)20-37)18-31(29)39-33(43)32-19-27(42)21-41(32)34(44)40-30-10-4-7-24-6-1-2-9-28(24)30/h1-10,13-14,17-18,22,27,32,42H,11-12,15-16,19,21,38H2,(H,39,43)(H,40,44)/t27-,32-,35?/m1/s1	XADXZHLGEJHMKA-GCMUPQKQSA-N	433402	US10562850, Compound 26b::US11066360, Compound 26b	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359610	438642333							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878885	CO[C@@]1(C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)c1ccccc1	InChI=1S/C36H37ClFN5O3/c1-46-35(25-7-3-2-4-8-25)22-31(43(23-35)34(45)41-28-15-13-27(37)14-16-28)33(44)42-30-21-26(12-17-29(30)38)36(39,19-18-24-10-11-24)32-9-5-6-20-40-32/h2-9,12-17,20-21,24,31H,10-11,18-19,22-23,39H2,1H3,(H,41,45)(H,42,44)/t31-,35-,36?/m1/s1	CVMRJSNJZIDFBV-HKGUWHNTSA-N	433403	US10562850, Compound 34d::US11066360, Compound 34d	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433403&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359339	438642334							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878886	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2CCCN2C(=O)Nc2ccc(Cl)cn2)c1	InChI=1S/C30H30ClFN6O2/c31-23-9-11-27(35-18-23)37-29(40)38-14-2-5-26(38)28(39)36-25-16-22(8-10-24(25)32)30(34,13-12-19-6-7-19)21-4-1-3-20(15-21)17-33/h1,3-4,8-11,15-16,18-19,26H,2,5-7,12-14,34H2,(H,36,39)(H,35,37,40)/t26-,30?/m1/s1	BHUHPYWDKYISKX-FIQOPJFZSA-N	433404	US10562850, Compound 13e::US11066360, Compound 13e	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433404	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433404&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281909	438642335							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878887	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(cc2)C(F)(F)F)c1	InChI=1S/C32H31F4N5O3/c33-26-11-8-23(31(38,13-12-19-4-5-19)22-3-1-2-20(14-22)17-37)15-27(26)40-29(43)28-16-25(42)18-41(28)30(44)39-24-9-6-21(7-10-24)32(34,35)36/h1-3,6-11,14-15,19,25,28,42H,4-5,12-13,16,18,38H2,(H,39,44)(H,40,43)/t25-,28-,31?/m1/s1	XJHRLFBDDQULDZ-JADDJLNISA-N	433405	US10562850, Compound 27b::US11066360, Compound 27b	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433405	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433405&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359579	438642336							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878888	CO[C@@]1(C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccccn1)c1ccccc1	InChI=1S/C35H36ClFN6O3/c1-46-34(24-7-3-2-4-8-24)20-29(43(22-34)33(45)42-31-15-13-26(36)21-40-31)32(44)41-28-19-25(12-14-27(28)37)35(38,17-16-23-10-11-23)30-9-5-6-18-39-30/h2-9,12-15,18-19,21,23,29H,10-11,16-17,20,22,38H2,1H3,(H,41,44)(H,40,42,45)/t29-,34-,35?/m1/s1	JDWCFHUHWOPMOA-QKKDUPNPSA-N	433406	US10562850, Compound 35a::US11066360, Compound 35a	Plasma kallikrein	Human	 75.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433406	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433406&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359597	438642337							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878889	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cn2)c1	InChI=1S/C30H30ClFN6O3/c31-22-7-9-27(35-16-22)37-29(41)38-17-23(39)14-26(38)28(40)36-25-13-21(6-8-24(25)32)30(34,11-10-18-4-5-18)20-3-1-2-19(12-20)15-33/h1-3,6-9,12-13,16,18,23,26,39H,4-5,10-11,14,17,34H2,(H,36,40)(H,35,37,41)/t23-,26-,30?/m1/s1	SXTWVJSROGJKOX-JRSXUWQBSA-N	433407	US10562850, Compound 14h::US11066360, Compound 14h	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359350	438642338							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878890	Nc1ccc(NC(=O)N2C[C@H](O)C[C@@H]2C(=O)Nc2cc(ccc2F)C(N)(CCC2CC2)c2cccc(c2)C#N)cc1	InChI=1S/C31H33FN6O3/c32-26-11-6-22(31(35,13-12-19-4-5-19)21-3-1-2-20(14-21)17-33)15-27(26)37-29(40)28-16-25(39)18-38(28)30(41)36-24-9-7-23(34)8-10-24/h1-3,6-11,14-15,19,25,28,39H,4-5,12-13,16,18,34-35H2,(H,36,41)(H,37,40)/t25-,28-,31?/m1/s1	XAOKWPPAZPSJST-JADDJLNISA-N	433408	US10562850, Compound 28b::US11066360, Compound 28b	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433408	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433408&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281910	438642339							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878891	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(N[S@](=O)C(C)(C)C)c1ccccc1	InChI=1S/C34H41ClFN5O4S/c1-33(2,3)46(44)40-34(17-16-22-10-11-22,23-8-6-5-7-9-23)24-12-14-27(36)28(18-24)38-31(42)29-19-26(45-4)21-41(29)32(43)39-30-15-13-25(35)20-37-30/h5-9,12-15,18,20,22,26,29,40H,10-11,16-17,19,21H2,1-4H3,(H,38,42)(H,37,39,43)/t26-,29-,34?,46-/m1/s1	QAXCQTYVFNJQHP-CUFRGZMTSA-N	433409	US10562850, Compound 66c::US11066360, Compound 66c	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433409	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433409&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750157	438642340							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878892	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(cc1)C#N)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C33H33FN6O3/c1-43-27-17-30(40(20-27)32(42)38-26-10-7-22(18-35)8-11-26)31(41)39-29-16-25(9-12-28(29)34)33(37,14-13-21-5-6-21)24-4-2-3-23(15-24)19-36/h2-4,7-12,15-16,21,27,30H,5-6,13-14,17,20,37H2,1H3,(H,38,42)(H,39,41)/t27-,30-,33?/m1/s1	XJUMLAKVFMNIFB-QDZZTBPHSA-N	433411	US10562850, Compound 15f::US11066360, Compound 15f	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433411	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433411&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359523	438642342							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878893	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cn2)c2ccccc2)c1	InChI=1S/C36H34ClFN6O3/c37-28-12-14-32(41-21-28)43-34(46)44-22-35(47,25-6-2-1-3-7-25)19-31(44)33(45)42-30-18-27(11-13-29(30)38)36(40,16-15-23-9-10-23)26-8-4-5-24(17-26)20-39/h1-8,11-14,17-18,21,23,31,47H,9-10,15-16,19,22,40H2,(H,42,45)(H,41,43,46)/t31-,35-,36?/m1/s1	HWYAZMPNKGJCSA-HKGUWHNTSA-N	433412	US10562850, Compound 29e::US11066360, Compound 29e	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359341	438642343							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878894	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C33H39ClFN5O4S/c1-32(2,3)45(44)39-33(15-12-21-4-5-21,22-13-16-36-17-14-22)23-6-11-27(35)28(18-23)38-30(42)29-19-26(41)20-40(29)31(43)37-25-9-7-24(34)8-10-25/h6-11,13-14,16-18,21,26,29,39,41H,4-5,12,15,19-20H2,1-3H3,(H,37,43)(H,38,42)/t26-,29-,33?,45-/m1/s1	QQLAJCNDSPMTIP-WZPBTREFSA-N	433413	US10562850, Compound 68a::US11066360, Compound 68a	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359286	438642344							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878895	CC(=O)O[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1cccc(c1)C#N	InChI=1S/C32H32ClFN6O4/c1-19(41)44-25-15-28(40(18-25)31(43)39-29-10-8-24(33)17-37-29)30(42)38-27-14-23(7-9-26(27)34)32(36,12-11-20-5-6-20)22-4-2-3-21(13-22)16-35/h2-4,7-10,13-14,17,20,25,28H,5-6,11-12,15,18,36H2,1H3,(H,38,42)(H,37,39,43)/t25-,28-,32?/m1/s1	SNYRVQXDQOVDKK-OHCGPUKPSA-N	433414	US10562850, Compound 14g::US11066360, Compound 14g	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359520	438642345							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878896	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cc2)c2ccccc2)c1	InChI=1S/C37H35ClFN5O3/c38-29-12-14-30(15-13-29)42-35(46)44-23-36(47,26-6-2-1-3-7-26)21-33(44)34(45)43-32-20-28(11-16-31(32)39)37(41,18-17-24-9-10-24)27-8-4-5-25(19-27)22-40/h1-8,11-16,19-20,24,33,47H,9-10,17-18,21,23,41H2,(H,42,46)(H,43,45)/t33-,36-,37?/m1/s1	BUDMXNKNTXVVSL-OJLDNJJMSA-N	433415	US10562850, Compound 30a::US11066360, Compound 30a	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433415	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433415&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359662	438642346							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878897	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C29H31ClFN5O3/c30-21-4-6-22(7-5-21)34-28(39)36-17-23(37)16-26(36)27(38)35-25-15-20(3-8-24(25)31)29(32,12-9-18-1-2-18)19-10-13-33-14-11-19/h3-8,10-11,13-15,18,23,26,37H,1-2,9,12,16-17,32H2,(H,34,39)(H,35,38)/t23-,26-,29?/m1/s1	KWYZMIIVFJJBEL-XATCSJPRSA-N	433416	US10562850, Compound 69a::US11066360, Compound 69a	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433416&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359521	438642347							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878899	O[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)[C@H](NCC1CC1)c1cccc(c1)C#N	InChI=1S/C30H29ClFN5O3/c31-22-7-9-23(10-8-22)35-30(40)37-17-24(38)14-27(37)29(39)36-26-13-21(6-11-25(26)32)28(34-16-18-4-5-18)20-3-1-2-19(12-20)15-33/h1-3,6-13,18,24,27-28,34,38H,4-5,14,16-17H2,(H,35,40)(H,36,39)/t24-,27-,28-/m1/s1	SQGKFOGUTRWMGA-RYRVMRHHSA-N	433417	US10562850, Compound 60a::US11066360, Compound 60a	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359582	438642348							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878900	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cn2)c1	InChI=1S/C28H30ClFN6O3/c29-20-4-6-25(33-15-20)35-27(39)36-16-21(37)14-24(36)26(38)34-23-13-19(3-5-22(23)30)28(31,10-7-17-1-2-17)18-8-11-32-12-9-18/h3-6,8-9,11-13,15,17,21,24,37H,1-2,7,10,14,16,31H2,(H,34,38)(H,33,35,39)/t21-,24-,28?/m1/s1	HQGRGSNARPYLCN-OWWYDEOISA-N	433418	US10562850, Compound 72c::US11066360, Compound 72c	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433418	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433418&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359595	438642349							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878901	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C29H32ClFN6O3/c1-40-22-15-25(37(17-22)28(39)36-26-7-5-21(30)16-34-26)27(38)35-24-14-20(4-6-23(24)31)29(32,11-8-18-2-3-18)19-9-12-33-13-10-19/h4-7,9-10,12-14,16,18,22,25H,2-3,8,11,15,17,32H2,1H3,(H,35,38)(H,34,36,39)/t22-,25-,29?/m1/s1	VGGJBRJWCKLWRW-LKXBVVHWSA-N	433419	US10562850, Compound 70c::US11066360, Compound 70c	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433419	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433419&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359295	438642350							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878902	CO[C@@H]1C[C@@H](N(C1)C(=O)Cc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C31H34ClFN4O3/c1-40-25-18-28(37(19-25)29(38)16-21-4-7-24(32)8-5-21)30(39)36-27-17-23(6-9-26(27)33)31(34,13-10-20-2-3-20)22-11-14-35-15-12-22/h4-9,11-12,14-15,17,20,25,28H,2-3,10,13,16,18-19,34H2,1H3,(H,36,39)/t25-,28-,31?/m1/s1	DHVCRRDPZVVRDO-JADDJLNISA-N	433420	US10562850, Compound 76e::US11066360, Compound 76e	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433420	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433420&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359516	438642351							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878903	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@@H]2C[C@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C35H39ClFN5O4S/c1-34(2,3)47(46)41-35(16-15-22-7-8-22,24-6-4-5-23(17-24)20-38)25-9-14-29(37)30(18-25)40-32(44)31-19-28(43)21-42(31)33(45)39-27-12-10-26(36)11-13-27/h4-6,9-14,17-18,22,28,31,41,43H,7-8,15-16,19,21H2,1-3H3,(H,39,45)(H,40,44)/t28-,31-,35?,47+/m0/s1	MJBIFAIWKFMNPW-GVNGFNKKSA-N	433421	US10562850, Compound 10b::US11066360, Compound 10b	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433421	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433421&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750013	438642352							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878904	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C30H33ClFN5O3/c1-40-24-17-27(37(18-24)29(39)35-23-7-5-22(31)6-8-23)28(38)36-26-16-21(4-9-25(26)32)30(33,13-10-19-2-3-19)20-11-14-34-15-12-20/h4-9,11-12,14-16,19,24,27H,2-3,10,13,17-18,33H2,1H3,(H,35,39)(H,36,38)/t24-,27-,30?/m1/s1	SAMYKJCENRVZAI-CPBGAKQSSA-N	433422	US10562850, Compound 71a::US11066360, Compound 71a	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433422	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433422&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359598	438642353							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878905	CCO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(NS(C)(=O)=O)c1ccncc1	InChI=1S/C31H36ClFN6O5S/c1-3-44-24-17-27(39(19-24)30(41)37-28-9-7-23(32)18-35-28)29(40)36-26-16-22(6-8-25(26)33)31(38-45(2,42)43,13-10-20-4-5-20)21-11-14-34-15-12-21/h6-9,11-12,14-16,18,20,24,27,38H,3-5,10,13,17,19H2,1-2H3,(H,36,40)(H,35,37,41)/t24-,27-,31?/m1/s1	WFRSAFQXIIEVRI-QPLSPKJVSA-N	433423	US10562850, Compound 55a::US11066360, Compound 55a	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433423&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359384	438642354							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878906	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C35H39ClFN5O4S/c1-34(2,3)47(46)41-35(16-15-22-7-8-22,24-6-4-5-23(17-24)20-38)25-9-14-29(37)30(18-25)40-32(44)31-19-28(43)21-42(31)33(45)39-27-12-10-26(36)11-13-27/h4-6,9-14,17-18,22,28,31,41,43H,7-8,15-16,19,21H2,1-3H3,(H,39,45)(H,40,44)/t28-,31-,35?,47-/m1/s1	MJBIFAIWKFMNPW-ZQUSZWJISA-N	433424	US10562850, Compound 4f::US11066360, Compound 4f	Plasma kallikrein	Human	 75.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433424	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433424&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750195	438642355							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878907	CCNC(CCC1CC1)(c1ccccc1)c1ccc(F)c(NC(=O)[C@H]2C[C@H](CN2C(=O)Nc2ccc(Cl)cn2)OC)c1	InChI=1S/C32H37ClFN5O3/c1-3-36-32(16-15-21-9-10-21,22-7-5-4-6-8-22)23-11-13-26(34)27(17-23)37-30(40)28-18-25(42-2)20-39(28)31(41)38-29-14-12-24(33)19-35-29/h4-8,11-14,17,19,21,25,28,36H,3,9-10,15-16,18,20H2,1-2H3,(H,37,40)(H,35,38,41)/t25-,28-,32?/m1/s1	LUJTUEOORDUTPD-OHCGPUKPSA-N	433425	US10562850, Compound 67b::US11066360, Compound 67b	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433425	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433425&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359524	438642356							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878908	CCO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(NC(C)=O)c1ccncc1	InChI=1S/C32H36ClFN6O4/c1-3-44-25-17-28(40(19-25)31(43)38-29-9-7-24(33)18-36-29)30(42)37-27-16-23(6-8-26(27)34)32(39-20(2)41,13-10-21-4-5-21)22-11-14-35-15-12-22/h6-9,11-12,14-16,18,21,25,28H,3-5,10,13,17,19H2,1-2H3,(H,37,42)(H,39,41)(H,36,38,43)/t25-,28-,32?/m1/s1	PBUISDDGSOCZAC-OHCGPUKPSA-N	433426	US10562850, Compound 56a::US11066360, Compound 56a	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433426&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359338	438642357							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878909	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C35H39ClFN5O4S/c1-34(2,3)47(46)41-35(16-15-22-7-8-22,24-6-4-5-23(17-24)20-38)25-9-14-29(37)30(18-25)40-32(44)31-19-28(43)21-42(31)33(45)39-27-12-10-26(36)11-13-27/h4-6,9-14,17-18,22,28,31,41,43H,7-8,15-16,19,21H2,1-3H3,(H,39,45)(H,40,44)/t28-,31+,35?,47+/m0/s1	MJBIFAIWKFMNPW-CVFBLIOSSA-N	433427	US10562850, Compound 9b::US11066360, Compound 9b	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433427	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433427&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750116	438642358							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878910	CCC1(O)C[C@@H](N(C1)C(=O)OC(C)(C)C)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(N[S@@](=O)C(C)(C)C)c1ccccn1	InChI=1S/C33H47FN4O5S/c1-8-32(41)20-26(38(21-32)29(40)43-30(2,3)4)28(39)36-25-19-23(14-15-24(25)34)33(17-16-22-12-13-22,27-11-9-10-18-35-27)37-44(42)31(5,6)7/h9-11,14-15,18-19,22,26,37,41H,8,12-13,16-17,20-21H2,1-7H3,(H,36,39)/t26-,32?,33?,44+/m1/s1	LFTPBCWVQLYAOS-PAOCNZHCSA-N	433428	US10562850, Compound 38d::US11066360, Compound 38d	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433428	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433428&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750041	438642359							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878911	CCNC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@H](CN2C(=O)Nc2ccc(Cl)cn2)OC)c1	InChI=1S/C31H36ClFN6O3/c1-3-36-31(13-10-20-4-5-20,21-11-14-34-15-12-21)22-6-8-25(33)26(16-22)37-29(40)27-17-24(42-2)19-39(27)30(41)38-28-9-7-23(32)18-35-28/h6-9,11-12,14-16,18,20,24,27,36H,3-5,10,13,17,19H2,1-2H3,(H,37,40)(H,35,38,41)/t24-,27-,31?/m1/s1	QJDWRBFXQVIGMO-QPLSPKJVSA-N	433429	US10562850, Compound 77a::US11066360, Compound 77a	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433429	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433429&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359543	438642360							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878912	CO[C@H]1C[C@H](N(C1)C(=O)Nc1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(N[S@](=O)C(C)(C)C)c1cccc(c1)C#N	InChI=1S/C36H41ClFN5O4S/c1-35(2,3)48(46)42-36(17-16-23-8-9-23,25-7-5-6-24(18-25)21-39)26-10-15-30(38)31(19-26)41-33(44)32-20-29(47-4)22-43(32)34(45)40-28-13-11-27(37)12-14-28/h5-7,10-15,18-19,23,29,32,42H,8-9,16-17,20,22H2,1-4H3,(H,40,45)(H,41,44)/t29-,32-,36?,48+/m0/s1	FHFCUESMMUURQU-AITDCACWSA-N	433430	US10562850, Compound 11d::US11066360, Compound 11d	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433430	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433430&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359327	438642361							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878913	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cn2)c2ccccc2)c1	InChI=1S/C34H34ClFN6O3/c35-26-9-11-30(39-20-26)41-32(44)42-21-33(45,23-4-2-1-3-5-23)19-29(42)31(43)40-28-18-25(8-10-27(28)36)34(37,15-12-22-6-7-22)24-13-16-38-17-14-24/h1-5,8-11,13-14,16-18,20,22,29,45H,6-7,12,15,19,21,37H2,(H,40,43)(H,39,41,44)/t29-,33-,34?/m1/s1	FRTGSCXDLYWPRX-KLPUMSTOSA-N	433431	US10562850, Compound 39h::US11066360, Compound 39h	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433431	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433431&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359380	438642362							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878914	CO[C@@]1(C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)C(F)(F)F	InChI=1S/C30H31ClF4N6O3/c1-44-28(30(33,34)35)15-24(41(17-28)27(43)40-25-7-5-21(31)16-38-25)26(42)39-23-14-20(4-6-22(23)32)29(36,11-8-18-2-3-18)19-9-12-37-13-10-19/h4-7,9-10,12-14,16,18,24H,2-3,8,11,15,17,36H2,1H3,(H,39,42)(H,38,40,43)/t24-,28-,29?/m1/s1	LTSHZLULDHEDGR-KWPCEPOYSA-N	433432	US10562850, Compound 57d::US11066360, Compound 57d	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433432	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433432&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359642	438642363							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878915	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2CCCN2C(=O)OCc2ccccc2)c1	InChI=1S/C36H41FN4O4S/c1-35(2,3)46(44)40-36(19-18-25-14-15-25,28-12-7-11-27(21-28)23-38)29-16-17-30(37)31(22-29)39-33(42)32-13-8-20-41(32)34(43)45-24-26-9-5-4-6-10-26/h4-7,9-12,16-17,21-22,25,32,40H,8,13-15,18-20,24H2,1-3H3,(H,39,42)/t32-,36?,46-/m1/s1	QQQBZZFKCABGOT-BJXIDKMJSA-N	433433	US10562850, Compound 12b::US11066360, Compound 12b	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433433	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433433&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750178	438642364							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878916	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cc2)c2ccccc2)c1	InChI=1S/C35H35ClFN5O3/c36-27-9-11-28(12-10-27)40-33(44)42-22-34(45,24-4-2-1-3-5-24)21-31(42)32(43)41-30-20-26(8-13-29(30)37)35(38,17-14-23-6-7-23)25-15-18-39-19-16-25/h1-5,8-13,15-16,18-20,23,31,45H,6-7,14,17,21-22,38H2,(H,40,44)(H,41,43)/t31-,34-,35?/m1/s1	XGAOCKOVDHHBDP-XUTBDEIESA-N	433434	US10562850, Compound 40a::US11066360, Compound 40a	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433434	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433434&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359646	438642365							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878917	CNC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cn2)c2ccccc2)c1	InChI=1S/C35H36ClFN6O3/c1-38-35(16-13-23-7-8-23,25-14-17-39-18-15-25)26-9-11-28(37)29(19-26)41-32(44)30-20-34(46,24-5-3-2-4-6-24)22-43(30)33(45)42-31-12-10-27(36)21-40-31/h2-6,9-12,14-15,17-19,21,23,30,38,46H,7-8,13,16,20,22H2,1H3,(H,41,44)(H,40,42,45)/t30-,34-,35?/m1/s1	BQQGWVYCWOCVBA-WELJHWQCSA-N	433435	US10562850, Compound 41a::US11066360, Compound 41a	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433435	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433435&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359385	438642366							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878918	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](O)CN2C(=O)Nc2ccc(cc2)C(F)(F)F)c1	InChI=1S/C36H39F4N5O4S/c1-34(2,3)50(49)44-35(16-15-22-7-8-22,25-6-4-5-23(17-25)20-41)26-11-14-29(37)30(18-26)43-32(47)31-19-28(46)21-45(31)33(48)42-27-12-9-24(10-13-27)36(38,39)40/h4-6,9-14,17-18,22,28,31,44,46H,7-8,15-16,19,21H2,1-3H3,(H,42,48)(H,43,47)/t28-,31-,35?,50-/m1/s1	LTFUBQNOSSPCKY-VGEWIOIYSA-N	433436	US10562850, Compound 27a::US11066360, Compound 27a	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433436	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433436&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			141522419	438642367							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878919	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](CN2C(=O)Nc2ccc(Cl)cn2)c2ccccc2)c1	InChI=1S/C34H34ClFN6O2/c35-27-9-11-31(39-20-27)41-33(44)42-21-24(23-4-2-1-3-5-23)18-30(42)32(43)40-29-19-26(8-10-28(29)36)34(37,15-12-22-6-7-22)25-13-16-38-17-14-25/h1-5,8-11,13-14,16-17,19-20,22,24,30H,6-7,12,15,18,21,37H2,(H,40,43)(H,39,41,44)/t24-,30+,34?/m0/s1	DYWQLBIPOOGHBX-DDNXYRJESA-N	433438	US10562850, Compound 47d::US11066360, Compound 47d	Plasma kallikrein	Human	 75.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433438	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433438&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359360	438642369							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878920	CCO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(NCC1CC1)c1cccc(c1)C#N	InChI=1S/C31H32ClFN6O3/c1-2-42-24-14-27(39(18-24)31(41)38-28-11-9-23(32)17-35-28)30(40)37-26-13-22(8-10-25(26)33)29(36-16-19-6-7-19)21-5-3-4-20(12-21)15-34/h3-5,8-13,17,19,24,27,29,36H,2,6-7,14,16,18H2,1H3,(H,37,40)(H,35,38,41)/t24-,27-,29?/m1/s1	GBDNLKBWBYVNQM-MPXLCVCVSA-N	433439	US10562850, Compound 58j::US11066360, Compound 58j	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433439	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433439&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359574	438642370							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878921	NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2)c2ccccc2)c1	InChI=1S/C30H31FN4O2/c31-25-12-11-24(30(33,14-13-20-9-10-20)23-8-4-5-21(15-23)18-32)16-26(25)35-28(36)27-17-29(37,19-34-27)22-6-2-1-3-7-22/h1-8,11-12,15-16,20,27,34,37H,9-10,13-14,17,19,33H2,(H,35,36)/t27-,29-,30?/m1/s1	JALINIFPYUQJSU-MODKJIOJSA-N	433440	US10562850, Compound 29d::US11066360, Compound 29d	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433440	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433440&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359296	438642371							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878922	C[C@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C29H32ClFN6O2/c1-18-14-25(37(17-18)28(39)36-26-7-5-22(30)16-34-26)27(38)35-24-15-21(4-6-23(24)31)29(32,11-8-19-2-3-19)20-9-12-33-13-10-20/h4-7,9-10,12-13,15-16,18-19,25H,2-3,8,11,14,17,32H2,1H3,(H,35,38)(H,34,36,39)/t18-,25+,29?/m0/s1	VKZOYNOIAPSODG-MEPMZUDESA-N	433441	US10562850, Compound 48d::US11066360, Compound 48d	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433441	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433441&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359603	438642372							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878923	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cn2)C2CC2)c1	InChI=1S/C31H34ClFN6O3/c32-23-6-8-27(36-17-23)38-29(41)39-18-30(42,20-3-4-20)16-26(39)28(40)37-25-15-22(5-7-24(25)33)31(34,12-9-19-1-2-19)21-10-13-35-14-11-21/h5-8,10-11,13-15,17,19-20,26,42H,1-4,9,12,16,18,34H2,(H,37,40)(H,36,38,41)/t26-,30-,31?/m1/s1	NPTYSNQRJNJEBG-FIWLTRSASA-N	433443	US10562850, Compound 59d::US11066360, Compound 59d	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433443	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433443&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359499	438642374							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878924	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2C[C@@H](CN2C(=O)Nc2ccc(Cl)cc2)N=[N+]=[N-])c1	InChI=1S/C35H38ClFN8O3S/c1-34(2,3)49(48)43-35(16-15-22-7-8-22,24-6-4-5-23(17-24)20-38)25-9-14-29(37)30(18-25)41-32(46)31-19-28(42-44-39)21-45(31)33(47)40-27-12-10-26(36)11-13-27/h4-6,9-14,17-18,22,28,31,43H,7-8,15-16,19,21H2,1-3H3,(H,40,47)(H,41,46)/t28-,31+,35?,49+/m0/s1	DDAHRDRLWWWJFX-IOQIPRRTSA-N	433444	US10562850, Compound 33b::US11066360, Compound 33b	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433444	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433444&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750144	438642375							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878925	C[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C29H32ClFN6O2/c1-18-14-25(37(17-18)28(39)36-26-7-5-22(30)16-34-26)27(38)35-24-15-21(4-6-23(24)31)29(32,11-8-19-2-3-19)20-9-12-33-13-10-20/h4-7,9-10,12-13,15-16,18-19,25H,2-3,8,11,14,17,32H2,1H3,(H,35,38)(H,34,36,39)/t18-,25-,29?/m1/s1	VKZOYNOIAPSODG-OYRGDXRMSA-N	433445	US10562850, Compound 49d::US11066360, Compound 49d	Plasma kallikrein	Human	 75.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433445	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433445&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359583	438642376							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878926	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)N1CCCCC1=O	InChI=1S/C29H35ClFN5O4/c1-40-21-15-25(36(17-21)29(39)34-26-12-9-20(30)16-32-26)28(38)33-23-14-19(8-10-22(23)31)24(11-7-18-5-6-18)35-13-3-2-4-27(35)37/h8-10,12,14,16,18,21,24-25H,2-7,11,13,15,17H2,1H3,(H,33,38)(H,32,34,39)/t21-,24?,25-/m1/s1	UWRIUUXMKXAKLB-TYIXABJVSA-N	433446	US10562850, Compound 44e::US11066360, Compound 44e	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433446	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433446&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359289	438642377							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878927	CO[C@@]1(C[C@@H](N(C1)C(=O)OC(C)(C)C)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(N[S@@](=O)C(C)(C)C)c1ccccn1)c1ccccc1	InChI=1S/C38H49FN4O5S/c1-35(2,3)48-34(45)43-25-37(47-7,27-13-9-8-10-14-27)24-31(43)33(44)41-30-23-28(18-19-29(30)39)38(21-20-26-16-17-26,32-15-11-12-22-40-32)42-49(46)36(4,5)6/h8-15,18-19,22-23,26,31,42H,16-17,20-21,24-25H2,1-7H3,(H,41,44)/t31-,37-,38?,49+/m1/s1	WSLPEHAMZHBFSH-DQCGMSCASA-N	433447	US10562850, Compound 34b::US11066360, Compound 34b	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433447	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433447&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750087	438642378							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878928	CCCO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C31H36ClFN6O3/c1-2-15-42-24-17-27(39(19-24)30(41)38-28-8-6-23(32)18-36-28)29(40)37-26-16-22(5-7-25(26)33)31(34,12-9-20-3-4-20)21-10-13-35-14-11-21/h5-8,10-11,13-14,16,18,20,24,27H,2-4,9,12,15,17,19,34H2,1H3,(H,37,40)(H,36,38,41)/t24-,27-,31?/m1/s1	STHHQVRGMGLOTE-QPLSPKJVSA-N	433448	US10562850, Compound 52d::US11066360, Compound 52d	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433448	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433448&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359656	438642379							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878929	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O	InChI=1S/C29H31ClFN5O4/c1-40-21-15-25(36(17-21)29(39)34-26-12-9-20(30)16-32-26)28(38)33-23-14-19(8-10-22(23)31)24(11-7-18-5-6-18)35-13-3-2-4-27(35)37/h2-4,8-10,12-14,16,18,21,24-25H,5-7,11,15,17H2,1H3,(H,33,38)(H,32,34,39)/t21-,24?,25-/m1/s1	XUORFTPJFLKHSK-TYIXABJVSA-N	433449	US10562850, Compound 42l::US10562850, Compound 43m::US11066360, Compound 43m	Plasma kallikrein	Human	 75.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433449	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433449&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359367	438642380							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878930	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)s1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C28H31ClFN5O3S/c1-38-20-15-23(35(16-20)27(37)34-25-7-6-24(29)39-25)26(36)33-22-14-19(4-5-21(22)30)28(31,11-8-17-2-3-17)18-9-12-32-13-10-18/h4-7,9-10,12-14,17,20,23H,2-3,8,11,15-16,31H2,1H3,(H,33,36)(H,34,37)/t20-,23-,28?/m1/s1	VSBGZUFFBZVRNX-JLGCCPRNSA-N	433450	US10562850, Compound 81h::US11066360, Compound 81h	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433450	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433450&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359293	438642381							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878931	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2CC(F)(F)CN2C(=O)Nc2ccc(Cl)cn2)c1	InChI=1S/C28H28ClF3N6O2/c29-20-4-6-24(35-15-20)37-26(40)38-16-27(31,32)14-23(38)25(39)36-22-13-19(3-5-21(22)30)28(33,10-7-17-1-2-17)18-8-11-34-12-9-18/h3-6,8-9,11-13,15,17,23H,1-2,7,10,14,16,33H2,(H,36,39)(H,35,37,40)/t23-,28?/m1/s1	MXPGAAAGVICXGQ-YFIOFSHDSA-N	433451	US10562850, Compound 53d::US11066360, Compound 53d	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433451	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433451&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359378	438642382							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878932	CO[C@@]1(C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1)c1ccccc1	InChI=1S/C35H36ClFN6O3/c1-46-34(24-5-3-2-4-6-24)20-30(43(22-34)33(45)42-31-12-10-27(36)21-40-31)32(44)41-29-19-26(9-11-28(29)37)35(38,16-13-23-7-8-23)25-14-17-39-18-15-25/h2-6,9-12,14-15,17-19,21,23,30H,7-8,13,16,20,22,38H2,1H3,(H,41,44)(H,40,42,45)/t30-,34-,35?/m1/s1	OHOVUWGMVUKSAR-WELJHWQCSA-N	433452	US10562850, Compound 45c::US11066360, Compound 45c	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433452	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433452&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359481	438642383							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878933	CNC(CCC1CC1)(c1ccnc(C)c1)c1ccc(F)c(NC(=O)[C@H]2C[C@H](CN2C(=O)Nc2ccc(Cl)cn2)OC)c1	InChI=1S/C31H36ClFN6O3/c1-19-14-22(11-13-35-19)31(34-2,12-10-20-4-5-20)21-6-8-25(33)26(15-21)37-29(40)27-16-24(42-3)18-39(27)30(41)38-28-9-7-23(32)17-36-28/h6-9,11,13-15,17,20,24,27,34H,4-5,10,12,16,18H2,1-3H3,(H,37,40)(H,36,38,41)/t24-,27-,31?/m1/s1	XOXPJMACNDGQNW-QPLSPKJVSA-N	433453	US10562850, Compound 79a::US11066360, Compound 79a	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433453	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433453&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359239	438642384							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878934	CCO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C30H34ClFN6O3/c1-2-41-23-16-26(38(18-23)29(40)37-27-8-6-22(31)17-35-27)28(39)36-25-15-21(5-7-24(25)32)30(33,12-9-19-3-4-19)20-10-13-34-14-11-20/h5-8,10-11,13-15,17,19,23,26H,2-4,9,12,16,18,33H2,1H3,(H,36,39)(H,35,37,40)/t23-,26-,30?/m1/s1	ZLNHEWKEIZHPQN-JRSXUWQBSA-N	433454	US10562850, Compound 51b::US11066360, Compound 51b	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433454	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433454&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359548	438642385							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878935	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccnc(C)c1	InChI=1S/C30H34ClFN6O3/c1-18-13-21(10-12-34-18)30(33,11-9-19-3-4-19)20-5-7-24(32)25(14-20)36-28(39)26-15-23(41-2)17-38(26)29(40)37-27-8-6-22(31)16-35-27/h5-8,10,12-14,16,19,23,26H,3-4,9,11,15,17,33H2,1-2H3,(H,36,39)(H,35,37,40)/t23-,26-,30?/m1/s1	LPEGODAKCBEEGJ-JRSXUWQBSA-N	433455	US10562850, Compound 46k::US11066360, Compound 46k	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433455	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433455&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359589	438642386							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878936	CCNC(CCC1CC1)(c1ccnc(C)c1)c1ccc(F)c(NC(=O)[C@H]2C[C@H](CN2C(=O)Nc2ccc(Cl)cn2)OC)c1	InChI=1S/C32H38ClFN6O3/c1-4-37-32(13-11-21-5-6-21,23-12-14-35-20(2)15-23)22-7-9-26(34)27(16-22)38-30(41)28-17-25(43-3)19-40(28)31(42)39-29-10-8-24(33)18-36-29/h7-10,12,14-16,18,21,25,28,37H,4-6,11,13,17,19H2,1-3H3,(H,38,41)(H,36,39,42)/t25-,28-,32?/m1/s1	GNWSEMQWKUFLTO-OHCGPUKPSA-N	433456	US10562850, Compound 78a::US11066360, Compound 78a	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433456	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433456&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359318	438642387							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878937	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(NC(C)=O)c1ccncc1	InChI=1S/C31H34ClFN6O4/c1-19(40)38-31(12-9-20-3-4-20,21-10-13-34-14-11-21)22-5-7-25(33)26(15-22)36-29(41)27-16-24(43-2)18-39(27)30(42)37-28-8-6-23(32)17-35-28/h5-8,10-11,13-15,17,20,24,27H,3-4,9,12,16,18H2,1-2H3,(H,36,41)(H,38,40)(H,35,37,42)/t24-,27-,31?/m1/s1	YDKUZDQMWDWMAQ-QPLSPKJVSA-N	433457	US10562850, Compound 73a::US11066360, Compound 73a	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433457	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433457&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359571	438642388							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878938	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C35H39ClFN5O4S/c1-34(2,3)47(46)41-35(16-15-22-7-8-22,24-6-4-5-23(17-24)20-38)25-9-14-29(37)30(18-25)40-32(44)31-19-28(43)21-42(31)33(45)39-27-12-10-26(36)11-13-27/h4-6,9-14,17-18,22,28,31,41,43H,7-8,15-16,19,21H2,1-3H3,(H,39,45)(H,40,44)/t28-,31+,35?,47-/m1/s1	MJBIFAIWKFMNPW-JMDKQSTQSA-N	433458	US10562850, Compound 5d::US11066360, Compound 5d	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433458	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433458&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750036	438642389					C04398		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878939	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@H]3C[C@H]3N2)c1	InChI=1S/C23H27FN4O/c24-18-4-3-17(13-20(18)28-22(29)21-12-15-11-19(15)27-21)23(25,8-5-14-1-2-14)16-6-9-26-10-7-16/h3-4,6-7,9-10,13-15,19,21,27H,1-2,5,8,11-12,25H2,(H,28,29)/t15-,19-,21-,23?/m1/s1	NFWCRWGBHZCTPQ-PUJXVWCHSA-N	433459	US10562850, Compound 80c::US11066360, Compound 80c	Plasma kallikrein	Human	 75.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433459	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433459&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359660	438642390							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878940	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(NS(C)(=O)=O)c1ccncc1	InChI=1S/C30H34ClFN6O5S/c1-43-23-16-26(38(18-23)29(40)36-27-8-6-22(31)17-34-27)28(39)35-25-15-21(5-7-24(25)32)30(37-44(2,41)42,12-9-19-3-4-19)20-10-13-33-14-11-20/h5-8,10-11,13-15,17,19,23,26,37H,3-4,9,12,16,18H2,1-2H3,(H,35,39)(H,34,36,40)/t23-,26-,30?/m1/s1	QWHRSMIIATYYJL-JRSXUWQBSA-N	433460	US10562850, Compound 74a::US11066360, Compound 74a	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433460	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433460&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359654	438642391							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878941	CO[C@@H]1C[C@H](N(C1)C(=O)N(C)c1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(N[S@](=O)C(C)(C)C)c1cccc(c1)C#N	InChI=1S/C37H43ClFN5O4S/c1-36(2,3)49(47)42-37(18-17-24-9-10-24,26-8-6-7-25(19-26)22-40)27-11-16-31(39)32(20-27)41-34(45)33-21-30(48-5)23-44(33)35(46)43(4)29-14-12-28(38)13-15-29/h6-8,11-16,19-20,24,30,33,42H,9-10,17-18,21,23H2,1-5H3,(H,41,45)/t30-,33+,37?,49-/m1/s1	QHCSTFXYRQGZKO-PCMIATBVSA-N	433461	US10562850, Compound 6d::US11066360, Compound 6d	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433461	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433461&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359575	438642392							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878942	CO[C@@H]1C[C@@H](N(C1)C(=O)c1ccc2cc[nH]c2c1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C32H34FN5O3/c1-41-25-18-29(38(19-25)31(40)22-5-4-21-9-15-36-27(21)16-22)30(39)37-28-17-24(6-7-26(28)33)32(34,12-8-20-2-3-20)23-10-13-35-14-11-23/h4-7,9-11,13-17,20,25,29,36H,2-3,8,12,18-19,34H2,1H3,(H,37,39)/t25-,29-,32?/m1/s1	MPOMDZOLMQUDDS-UCGPOHEZSA-N	433462	US10562850, Compound 82a::US11066360, Compound 82a	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433462	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433462&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281871	438642393							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878943	NC(CCC1CC1)(c1ccncc1)c1ccc(F)c(NC(=O)[C@H]2C[C@@](O)(CN2C(=O)Nc2ccc(Cl)cn2)C(F)(F)F)c1	InChI=1S/C29H29ClF4N6O3/c30-20-4-6-24(37-15-20)39-26(42)40-16-27(43,29(32,33)34)14-23(40)25(41)38-22-13-19(3-5-21(22)31)28(35,10-7-17-1-2-17)18-8-11-36-12-9-18/h3-6,8-9,11-13,15,17,23,43H,1-2,7,10,14,16,35H2,(H,38,41)(H,37,39,42)/t23-,27-,28?/m1/s1	VGCFWQXZFXYVKN-AFJRLBRLSA-N	433463	US10562850, Compound 54g::US11066360, Compound 54g	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433463	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433463&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359502	438642394							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878944	CO[C@@H]1C[C@@H](N(C1)C(=O)N(C)c1ccc(Cl)cc1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(N[S@](=O)C(C)(C)C)c1cccc(c1)C#N	InChI=1S/C37H43ClFN5O4S/c1-36(2,3)49(47)42-37(18-17-24-9-10-24,26-8-6-7-25(19-26)22-40)27-11-16-31(39)32(20-27)41-34(45)33-21-30(48-5)23-44(33)35(46)43(4)29-14-12-28(38)13-15-29/h6-8,11-16,19-20,24,30,33,42H,9-10,17-18,21,23H2,1-5H3,(H,41,45)/t30-,33-,37?,49-/m1/s1	QHCSTFXYRQGZKO-VVHKCOIQSA-N	433464	US10562850, Compound 6c::US11066360, Compound 6c	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433464	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433464&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750114	438642395							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878945	CO[C@@H]1C[C@@H](N(C1)C(=O)c1ccc2c(Cl)c[nH]c2c1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C32H33ClFN5O3/c1-42-23-16-29(39(18-23)31(41)20-4-6-24-25(33)17-37-27(24)14-20)30(40)38-28-15-22(5-7-26(28)34)32(35,11-8-19-2-3-19)21-9-12-36-13-10-21/h4-7,9-10,12-15,17,19,23,29,37H,2-3,8,11,16,18,35H2,1H3,(H,38,40)/t23-,29-,32?/m1/s1	WCQRTVWTSVWTGK-ULZFTAANSA-N	433465	US10562850, Compound 83a::US11066360, Compound 83a	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433465	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433465&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281889	438642396							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878946	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cc(ccc1F)C(CCC1CC1)n1ccccc1=O	InChI=1S/C29H31ClFN5O4/c1-40-21-15-25(36(17-21)29(39)34-26-12-9-20(30)16-32-26)28(38)33-23-14-19(8-10-22(23)31)24(11-7-18-5-6-18)35-13-3-2-4-27(35)37/h2-4,8-10,12-14,16,18,21,24-25H,5-7,11,15,17H2,1H3,(H,33,38)(H,32,34,39)/t21-,24?,25-/m1/s1	XUORFTPJFLKHSK-TYIXABJVSA-N	433449	US10562850, Compound 42l::US10562850, Compound 43m::US11066360, Compound 43m	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433449	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433449&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359367	438642380							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878947	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@H]2CCCN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C35H39ClFN5O3S/c1-34(2,3)46(45)41-35(18-17-23-9-10-23,25-7-4-6-24(20-25)22-38)26-11-16-29(37)30(21-26)40-32(43)31-8-5-19-42(31)33(44)39-28-14-12-27(36)13-15-28/h4,6-7,11-16,20-21,23,31,41H,5,8-10,17-19H2,1-3H3,(H,39,44)(H,40,43)/t31-,35?,46-/m1/s1	QMMABOBRWWOXDM-BLQLWLDUSA-N	433467	US10562850, Compound 7b::US11066360, Compound 7b	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433467	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433467&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750056	438642397							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878948	CO[C@@H]1C[C@@H](N(C1)C(=O)c1ccc(Cl)c(N)c1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C30H33ClFN5O3/c1-40-22-16-27(37(17-22)29(39)19-4-6-23(31)25(33)14-19)28(38)36-26-15-21(5-7-24(26)32)30(34,11-8-18-2-3-18)20-9-12-35-13-10-20/h4-7,9-10,12-15,18,22,27H,2-3,8,11,16-17,33-34H2,1H3,(H,36,38)/t22-,27-,30?/m1/s1	SUBHSHKRDIKUKN-MPCSXZBSSA-N	433468	US10562850, Compound 84a::US11066360, Compound 84a	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433468	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433468&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281821	438642398							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878949	CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(Cl)cn1)C(=O)Nc1cccc(c1)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C29H33ClN6O3/c1-39-24-16-25(36(18-24)28(38)35-26-8-7-22(30)17-33-26)27(37)34-23-4-2-3-21(15-23)29(31,12-9-19-5-6-19)20-10-13-32-14-11-20/h2-4,7-8,10-11,13-15,17,19,24-25H,5-6,9,12,16,18,31H2,1H3,(H,34,37)(H,33,35,38)/t24-,25-,29?/m1/s1	NBIGEYRETZSFJW-COJIHYBUSA-N	433469	US10562850, Compound 75e::US11066360, Compound 75e	Plasma kallikrein	Human	<50.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433469	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433469&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137359567	438642399							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878950	CC(C)(C)[S@@](=O)NC(CCC1CC1)(c1cccc(c1)C#N)c1ccc(F)c(NC(=O)[C@@H]2CCCN2C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C35H39ClFN5O3S/c1-34(2,3)46(45)41-35(18-17-23-9-10-23,25-7-4-6-24(20-25)22-38)26-11-16-29(37)30(21-26)40-32(43)31-8-5-19-42(31)33(44)39-28-14-12-27(36)13-15-28/h4,6-7,11-16,20-21,23,31,41H,5,8-10,17-19H2,1-3H3,(H,39,44)(H,40,43)/t31-,35?,46+/m0/s1	QMMABOBRWWOXDM-GFRNEHCDSA-N	433470	US10562850, Compound 8b::US11066360, Compound 8b	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433470	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433470&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750194	438642400							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878951	CO[C@@H]1C[C@@H](N(C1)C(=O)c1ccc(F)c(N)c1)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C30H33F2N5O3/c1-40-22-16-27(37(17-22)29(39)19-4-6-23(31)25(33)14-19)28(38)36-26-15-21(5-7-24(26)32)30(34,11-8-18-2-3-18)20-9-12-35-13-10-20/h4-7,9-10,12-15,18,22,27H,2-3,8,11,16-17,33-34H2,1H3,(H,36,38)/t22-,27-,30?/m1/s1	YLALVSNPTPTFII-MPCSXZBSSA-N	433471	US10562850, Compound 85a::US11066360, Compound 85a	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433471&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281882	438642401							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878952	CO[C@@H]1C[C@@H](N(C1)C(=O)c1cccc(c1)C#N)C(=O)Nc1cc(ccc1F)C(N)(CCC1CC1)c1ccncc1	InChI=1S/C31H32FN5O3/c1-40-25-17-28(37(19-25)30(39)22-4-2-3-21(15-22)18-33)29(38)36-27-16-24(7-8-26(27)32)31(34,12-9-20-5-6-20)23-10-13-35-14-11-23/h2-4,7-8,10-11,13-16,20,25,28H,5-6,9,12,17,19,34H2,1H3,(H,36,38)/t25-,28-,31?/m1/s1	IYLXYRHOQVZYRJ-JADDJLNISA-N	433472	US10562850, Compound 86a::US11066360, Compound 86a	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433472	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433472&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			135281782	438642402							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
878953	CO[C@@H]1C[C@@H](N(C1)S(=O)(=O)c1cccc2c(Cl)cccc12)C(=O)Nc1cc(ccc1F)C(CCC1CC1)(N[S@](=O)C(C)(C)C)c1ccncc1	InChI=1S/C37H42ClFN4O5S2/c1-36(2,3)49(45)42-37(18-15-24-11-12-24,25-16-19-40-20-17-25)26-13-14-31(39)32(21-26)41-35(44)33-22-27(48-4)23-43(33)50(46,47)34-10-6-7-28-29(34)8-5-9-30(28)38/h5-10,13-14,16-17,19-21,24,27,33,42H,11-12,15,18,22-23H2,1-4H3,(H,41,44)/t27-,33-,37?,49-/m1/s1	HNTKROBOBZDWET-MYCXRTHGSA-N	433473	US10562850, Compound 87b::US11066360, Compound 87b	Plasma kallikrein	Human	>100.0								US Patent		10.7270/Q2FR001P		aid1804212	US10562850	Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Vogeti, L	2/18/2020	11/22/2020	BioCryst Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=433473	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=433473&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			145750019	438642403							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3